Receive Our Newsletter

Stay Connected

Sign Up For Our Newsletter

Join our community of physicians, scientists, researchers, engineers, providers, payers and patients.  Learn more about our process and an FDA-approved pivotal/Phase III trial starting soon for the potential of our device and cell therapy to treat pain and function associated with knee osteoarthritis.